These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 2880681

  • 1. Thyrotropin-binding inhibitory immunoglobulin in patients with Graves' disease. Measurement and relationship to numeric abnormality of T cells.
    Gupta MK, Valenzuela R, Naghshineh S, Turinic R, Elliot I, Schumacher OP.
    Cleve Clin Q; 1986; 53(3):291-7. PubMed ID: 2880681
    [No Abstract] [Full Text] [Related]

  • 2. IgG heavy-chain subclass restriction of thyrotropin-binding inhibitory immunoglobulins in Graves' disease.
    Weetman AP, Byfield PG, Black C, Reimer CB.
    Eur J Clin Invest; 1990 Aug; 20(4):406-10. PubMed ID: 1977589
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A new method for assessing the thyrotropin binding inhibitory activity in the immunoglobulins and whole serum of patients with Graves' disease.
    Borges M, Ingbar JC, Endo K, Amir S, Uchimura H, Nagataki S, Ingbar SH.
    J Clin Endocrinol Metab; 1982 Mar; 54(3):552-8. PubMed ID: 6120179
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Correlation between thyroid adenylate cyclase-stimulating and thyrotropin-binding inhibitor immunoglobulins in Graves' disease.
    Chang TC, Chen FW, Chang CC, Liaw KY.
    Taiwan Yi Xue Hui Za Zhi; 1985 May; 84(5):579-85. PubMed ID: 2864384
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K, Yamazaki K, Yamada E, Kanaji Y, Miura M, Obara T.
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Studies on thyrotrophin receptor antibodies in patients with euthyroid Graves' disease.
    Kasagi K, Hatabu H, Tokuda Y, Iida Y, Endo K, Konishi J.
    Clin Endocrinol (Oxf); 1988 Oct; 29(4):357-66. PubMed ID: 2908031
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. TSH receptor binding and thyroid stimulation by sera from patients with Graves' disease.
    Ginsberg J, Shewring G, Smith BR.
    Clin Endocrinol (Oxf); 1983 Sep; 19(3):305-11. PubMed ID: 6138173
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.